Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Metastatic castration-resistant prostate cancer primarily affects elderly men. In this post hoc analysis we investigated the safety and efficacy of abiraterone acetate in elderly (≥75 years) and younger (<75 years) patient subgroups at the prespecified interim analysis (55% of total over...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Urol
Hoofdauteurs: Smith, Matthew R., Rathkopf, Dana E., Mulders, Peter. F.A., Carles, Joan, Van Poppel, Hendrik, Li, Jinhui, Kheoh, Thian, Griffin, Thomas W., Molina, Arturo, Ryan, Charles J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129174/
https://ncbi.nlm.nih.gov/pubmed/26151676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.07.004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items